Theraclone’s Influenza Antibody Alliance With Japanese Co
Taskin Ahmed
Abstract
Theraclone Sciences and Japanese pharma company, Zenyaku Kogyo, inked a research and development agreement for flu-fighting antibodies using Theraclone’s I-START™ technology.
Add comment

This work is licensed under a Creative Commons Attribution 3.0 License.